Inhibition of insulin signaling by oxidized low density lipoprotein: Protective effect of the antioxidant Vitamin E

Atherosclerosis

Volumn 175, Issue 1, 2004, Pages 23-30

  Mazière, Cécile ^a   Morlière, Patrice ^b   Santus, René ^c   Marcheux, Virginie ^a   Louandre, Christophe ^a   Conte, Marie Alix ^a   Mazière, Jean Claude ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

Author keywords

Cu2+ oxidized low density lipoprotein; CuLDL; INS; insulin; Insulin signaling; Oxidative stress; Oxidized LDL; reactive oxygen species; ROS

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; COPPER ION; CYTOKINE; DNA; HORMONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR AP 1;

ANTIOXIDANT ACTIVITY; ARTICLE; BINDING AFFINITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; LIPOPHILICITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DNA BINDING; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ANTIOXIDANTS; CELLS, CULTURED; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; HUMANS; INSULIN; LIPOPROTEINS, LDL; NF-KAPPA B; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; VITAMIN E;

EID: 2942516734     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.02.006     Document Type: Article

References (35)

1. Berlett B.S., Stadtman E.R. Protein oxidation in aging, disease and oxidative stress. J Biol Chem. 272:1997;20313-20316
2. Ceriello A. New insights on oxidative stress and diabetic complications may lead to a causal antioxidant therapy. Diabetes Care. 26:2003;1589-1596
3. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 414:2001;813-820
4. Evans J.L., Goldfine I.D., Maddux B.A., Grodsky G.M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev. 23:2002;599-622
5. DeFronso R.A., Bonadonna R.C., Ferannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care. 15:1992;318-368
6. Cross C.E., Halliwell B., Borish E.T., et al. Oxygen radicals and human disease. Ann Int Med. 107:1987;526-545
7. Seedorf K. Intracellular signaling by growth factors. Metabolism. 44:1995;24-32
8. Hansen L.L., Ikeda Y., Olsen G.S., Busch A.K., Mosthaf L. Insulin signaling is inhibited by micromolar concentrations of H(2)O(2). Evidence for a role of H(2)O(2) in tumor necrosis factor alpha-mediated insulin resistance. J Biol Chem. 274:1999;25078-25084
9. Blair A.S., Hajduch E., Litherland G.J., Hundal H.S. Regulation of glucose transport and glycogen synthesis in L6 muscle cells during oxidative stress. Evidence for cross-talk between the insulin and SAPK2/p38 mitogen-activated protein kinase signaling pathways. J Biol Chem. 274:1999;36293-36299
10. Maddux B.A., See W., Lawrence J.C. Jr., et al. Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of α-lipoic acid. Diabetes. 50:2001;404-410
11. Najib S., Sanchez-margalet V. Homocysteine thiolactone inhibits insulin siganling, and glutathione has a protective effect. J Mol Endocrinol. 27:2001;85-91
12. Chisolm G.M., Steinberg D. The oxidative modification hypothesis of atherosclerosis: an overview. Free Radic Biol Med. 28:2000;1815-1826
13. Steinbrecher U.P., Parthasarathy S., Leake D.S., Witztum J.L., Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U.S.A. 81:1984;3884-3887
14. Li D., Yang B., Mehta J.L. Ox-LDL induces apoptosis in human coronary artery endothelial cells: role of PKC, PTK, bcl-2 and Fas. Am J Physiol. 275:1998;H568-576
15. Augé N., Escargueil-Blanc I., Lajoie-Mazenc I., et al. Potential role for ceramide in mitogen-activated protein kinase activation and proliferation of vascular smooth muscle cells induced by oxidized low density lipoprotein. J Biol Chem. 273:1998;12893-12900
16. Mazière C., Auclair M., Djavaheri-Mergny M., Packer L., Mazière J.C. Oxidized low density lipoproteins induce activation of the transcription factor NFκB in fibroblasts. Biochem Mol Biol Int. 39:1996;1201-1207
17. Mazière C., Djavaheri-Mergny M., Frey-Fressart V., Delattre J., Mazière J.C. Copper and cell-oxidized low density lipoprotein induces activator protein 1 in fibroblasts, endothelial and smooth muscle cells. FEBS Lett. 409:1997;351-356
18. Mazière C., Alimardani G., Dantin F., et al. Oxidized LDL activate STAT1 and STAT3 transcription factors. Possible involvement of reactive oxygen species. FEBS Lett. 448:1999;49-52
19. Havel R.J., Eden M.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 34:1955;1345-1353
20. Scott J.A., Homcy C.J., Khaw B.A., Rabito C.A. Quantitation of intracellular oxidation in a renal epithelial cell line. Free Radic Biol Med. 4:1988;79-83
21. Dignam J.D., Levovitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489
22. 2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase. J Clin Invest. 89:1992;1006-1013
23. Spagnoli A., Spadoni G.L., Sesti G., et al. Effect of insulin on hydrogen peroxide production by human polymorphonuclear leukocytes. Studies with monoclonal anti-insulin receptor antibodies, and an agonist and inhibitor of protein kinase C. Horm Res. 43:1995;286-293
24. 2 generation in human adipocyte plasma membranes is mediated by Galphai2. J Biol Chem. 272:1997;10135-10143
25. Yang C.M., Chiu C.T., Wang C.C., et al. Activation of mitogen-activated protein kinase by oxidized low density lipoprotein in canine cultured vascular smooth muscle cells. Cell Signal. 12:2000;205-214
26. 2. Role in cell survival following oxidant injury. J Biol Chem. 271:1996;4138-4142
27. Mazière C., Meignotte A., Dantin F., Conte M.A., Mazière J.C. Oxidized LDL induces an oxidative stress and activates the tumor suppressor p53 in MRC5 human fibroblasts. Biochim Biophys Res Commun. 276:2000;718-723
28. Sen C.K., Packer L. Antioxidant and regulation of gene transcription. FASEB J. 10:1996;709-720
29. Morel Y., Barouki R. Repression of gene expression by oxidative stress. Biochem J. 342:1999;481-496
30. Rudich A., Tirosh A., Potashnik R., et al. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes. 47:1998;1562-1569
31. Tirosh A., Potashnik R., Bashan N., Rudish A. Oxidative stress disrupts insulin-induced redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes: a putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation. J Biol Chem. 274:1999;10595-10602
32. Evans J.L., Goldfine I.D., Maddux B.A., Grodsky G.M. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes. 52:2003;1-8
33. Caballero B. Vitamin E improves the action of insulin. Nutr Rev. 51:1993;339-340
34. Mayer-Davis E.J., Costacou T., King I., Zaccaro D.J., Bell R.A. Dietary vitamin E in relation to incidence of type 2 diabetes: Insulin Resistance and Atherosclerose Study (IRAS). Diabetes Care. 25:2002;2172-2177
35. Halliwell B. Oxidative stress in cell culture: an under-appreciated problem? FEBS Lett. 540:2003;3-6